|Articles|October 1, 2001

SurgiLight to get $1.3 million licensing fee in Taiwanese deal

Orlando-SurgiLight Inc. will sell license rights to its IR-3000to a Taiwanese company for $1.3 million. The equipment is used to treata variety of conditions, including presbyopia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME